Get started
Author

Cynthia A. Flannery

Observed names: Cynthia A Flannery, Cynthia Flannery
Observed institution: Exact Sciences (United States)
OpenAlex ID: A5002784919
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay
2023 · Hao-Kuen Lin, Thuy Can, et al. · The Oncologist · 7
PDF
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer
2024 · Madappa N Kundranda, Ariane C Kemkes, et al. · The Oncologist · 2
BRAF mutation classes and co-occurring mutations in NSCLC.
2022 · Jiaxin Niu, Cynthia A. Flannery, et al. · Journal of Clinical Oncology · 2
Abstract PO5-13-06: Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes
2024 · Gargi Basu, Niru Chennagiri, et al. · Cancer Research · 1
ECOG-ACRIN E2197: Comparison of HER2 gene expression by RT-PCR across all HER2 immunohistochemistry groups with recurrence analysis.
2023 · Nhu Thuy Can, John Bennett, et al. · Journal of Clinical Oncology · 1
PDF
Genomic profiling of biliary tract carcinomas by their location.
2023 · Zoran Gatalica, David K. Edwards, et al. · Journal of Clinical Oncology · 1
Age-associated mutations in RAS-mutated versus RAS-nonmutated metastatic colorectal cancer.
2022 · Madappa N. Kundranda, Ariane C. Kemkes, et al. · Journal of Clinical Oncology · 1
Abstract P3-03-30: Molecular landscape of breast cancer in pre- and postmenopausal women
2025 · Sameer Udhane, Pawan Noel, et al. · Clinical Cancer Research
Abstract P4-03-25: Actionable gene alterations affecting the PI3K/AKT and MAPK signaling pathways in breast cancer
2025 · Gargi D. Basu, Karen White, et al. · Clinical Cancer Research
ESR1 alterations in gynecologic cancers
2024 · Aysegul Balyimez, Gargi Basu, et al. · Gynecologic Oncology
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy
2024 · Sanaz Nourmohammadi Abadchi, Daniela C. Salles, et al. · British Journal of Urology
PDF
Abstract PO2-06-10: Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in triple negative breast cancer patients
2024 · Gargi Basu, Janine Lobello, et al. · Cancer Research
Abstract PO5-13-05: Comparison of whole exome, whole transcriptome genomic profiling and targeted sequencing with 50-gene panels
2024 · Snehal Thakkar, David Hall, et al. · Cancer Research
Abstract A022: Assessment of clonal and subclonal PIK3CA mutations in patients with breast cancer
2024 · Sameer S Udhane, Fadel Alyaqoub, et al. · Cancer Research
Oncogenic fusions in renal cell carcinoma.
2024 · Gargi D. Basu, Katon Kras, et al. · Journal of Clinical Oncology
Abstract A070: Genomic profiling of pancreatic cancer by KRAS status
2024 · Gargi D. Basu, Snehal G. Thakkar, et al. · Cancer Research
219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients
2023 · Gargi D Basu, Janine LoBello, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract P2-23-14: Molecular characterization of HER2-low invasive breast carcinoma by quantitative RT-PCR using Oncotype DX®
2023 · Mariya Rozenblit, Hao-Kuen Lin, et al. · Cancer Research
Abstract P2-23-11: Quantitative gene expression by RT-PCR in histologic subtypes of invasive breast carcinoma: an update in nearly one million cases
2023 · Nhu Thuy Can, Cynthia A. Flannery, et al. · Cancer Research
Molecular profiling to identify potential therapeutic targets in hepatocellular carcinoma.
2022 · Madappa N. Kundranda, Josh Routh, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type